Smartiks Yazilim A.S. (IST:SMART)

Elevation Oncology Cash Flow Statement

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	6.69	12.32	64.94	-45.13	3.81	3.74
Depreciation & Amortization	-7.19	8.76	8.09	2.57	1.38	1.51
Other Amortization	105.45	85.58	98.42	67.57	14.63	10.84
Asset Writedown & Restructuring Costs	-	-	-	9.29	2.03	0.43
Loss (Gain) From Sale of Investments	-0.06	-0.06	-0.03	-	-	-
Provision & Write-off of Bad Debts	0.94	0.99	-1.39	-	3.81	0.94
Other Operating Activities	-33.57	7.47	-21.45	64.8	-1.73	0.51
Change in Accounts Receivable	10.61	20.3	-52.79	-26.66	-3.27	-2.57
Change in Inventory	9.96	-9.82	0.17	-0.17	0.34	0.69
Change in Accounts Payable	0.24	2.48	11.16	5.09	2.39	-1.78
Change in Unearned Revenue	-0.11	-0.2	-0.04	-7.57	-0.87	2.89
Change in Other Net Operating Assets	15.56	-10.79	-0.95	-22.25	2.2	0.74
Operating Cash Flow	108.52	117.02	106.13	47.53	24.71	17.94
Operating Cash Flow Growth	-18.48%	10.26%	123.28%	92.33%	37.75%	1.58%
Capital Expenditures	-0.2	-0.86	-0.96	-1.75	-0.62	-0.12
Sale of Property, Plant & Equipment	-	-	-	-	0.05	0.45
Sale (Purchase) of Intangibles	-138.43	-141.1	-104.25	-47.08	-23.34	-18.05
Other Investing Activities	0.34	0.28	0.23	-	-	-
Investing Cash Flow	-138.29	-141.67	-104.98	-48.83	-23.91	-17.72
Long-Term Debt Issued	-	57.47	20.43	-	6.92	7.54
Long-Term Debt Repaid	-	-1.86	-18.19	-15.97	-6.23	-7.49
Net Debt Issued (Repaid)	48.53	55.62	2.23	-15.97	0.68	0.05
Other Financing Activities	-24.14	-32.1	-8.45	-	-0.72	-0.43
Financing Cash Flow	24.39	23.52	-6.22	-15.97	-0.04	-0.39
Miscellaneous Cash Flow Adjustments	0.34	0.49	1.57	8.05	-	-
Net Cash Flow	-5.05	-0.63	-3.5	-9.22	0.76	-0.16
Free Cash Flow	108.31	116.17	105.17	45.78	24.09	17.82
Free Cash Flow Growth	-17.66%	10.45%	129.73%	90.04%	35.16%	1.69%
Free Cash Flow Margin	53.81%	57.30%	43.46%	42.70%	66.25%	65.52%
Free Cash Flow Per Share	3.40	3.65	3.30	1.44	0.76	0.56
Cash Interest Paid	32.1	32.1	8.45	-	1.4	1.09
Levered Free Cash Flow	-29.56	-22.31	-12.46	-1.92	-6.36	-4.43
Unlevered Free Cash Flow	-7.31	-2.25	-7.17	0.65	-5.48	-3.83

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.